Freeze drying of peptide drugs self-associated with long-circulating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles
- 22 May 2008
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 356 (1-2), 345-350
- https://doi.org/10.1016/j.ijpharm.2008.01.014
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Human VIP-α: A long-acting, biocompatible and biodegradable peptide nanomedicine for essential hypertensionPeptides, 2006
- Proprietary Rel-Ease™ drug delivery technology: opportunity for sustained delivery of peptides, proteins and small moleculesExpert Opinion on Drug Delivery, 2006
- Novel concepts of neuropeptide-based drug therapy: Vasoactive intestinal polypeptide and its receptorsEuropean Journal of Pharmacology, 2006
- Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetesDiabetes & Metabolism, 2005
- Drug delivery into the brain using poly(lactide-co-glycolide) microspheresExpert Opinion on Drug Delivery, 2005
- Interactions of VIP, Secretin and PACAP1-38 with Phospholipids: A Biological Paradox RevisitedCurrent Pharmaceutical Design, 2003
- Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(1—38)Journal of Applied Physiology, 2002
- A novel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo.Pharmaceutical Research, 1999
- Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humansAmerican Journal of Physiology-Endocrinology and Metabolism, 1997
- Poly(Pro)II Helixes in Globular Proteins: Identification and Circular Dichroic AnalysisBiochemistry, 1994